EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.1.1.153 | 6,7-dihydropteridine reductase deficiency |
11902126 |
Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. |
diagnostic usage ongoing research unassigned |
2 2 0 |
1.1.1.153 | 6,7-dihydropteridine reductase deficiency |
29116116 |
Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients. |
causal interaction therapeutic application unassigned |
4 4 0 |
1.1.1.153 | 6-pyruvoyltetrahydropterin synthase deficiency |
29116116 |
Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients. |
causal interaction therapeutic application unassigned |
4 4 0 |
1.1.1.153 | 6-pyruvoyltetrahydropterin synthase deficiency |
34245036 |
Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry. |
causal interaction unassigned |
4 0 |
1.1.1.153 | Adenocarcinoma |
28062797 |
Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis. |
diagnostic usage unassigned |
1 0 |
1.1.1.153 | Adenoma |
15181092 |
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 1 |
1.1.1.153 | Adenoma |
28062797 |
Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis. |
diagnostic usage unassigned |
1 0 |
1.1.1.153 | Adrenal Cortex Neoplasms |
15181092 |
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 1 |
1.1.1.153 | Adrenocortical Carcinoma |
15181092 |
Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 4 1 |
1.1.1.153 | Adrenoleukodystrophy |
23430877 |
Levodopa response reveals sepiapterin reductase deficiency in a female heterozygote with adrenoleukodystrophy. |
causal interaction unassigned |
4 0 |